Business Context and Reporting Period
This Form 8-K filing by Achieve Life Sciences, Inc. reports on corporate governance events occurring on October 26, 2017, specifically the Annual Meeting of Stockholders. The report details the election of directors, ratification of auditors, approval of equity plans, and amendments to the Certificate of Incorporation.
Financial Metrics
This filing is a current report regarding corporate actions and does not contain financial statements. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes and Voting Results
The following matters were submitted to a vote of security holders and approved:
- Director Elections: Seven nominees (Anthony Clarke, Scott Cormack, Donald Joseph, Martin Mattingly, Jay Moyes, Stewart Parker, and Richard Stewart) were elected. All received over 8.3 million "For" votes.
- Corporate Governance Amendment: Stockholders approved an amendment to eliminate cumulative voting for the election of directors. The Certificate of Amendment was filed with the Delaware Secretary of State on October 31, 2017.
- Auditor Ratification: PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2017.
- Equity Plans: The 2017 Equity Incentive Plan and the 2017 Employee Stock Purchase Plan were both approved.
- Executive Compensation: The non-binding advisory vote on executive compensation was approved. Stockholders indicated a preference for future advisory votes to be held every three years.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, specific risks, contingencies, or unusual items. The document is strictly limited to reporting the results of the stockholder vote and the subsequent filing of the Certificate of Amendment.
Key Facts for Investor Verification
- Verify the effective date of the elimination of cumulative voting (filed October 31, 2017).
- Confirm the composition of the newly elected Board of Directors.
- Note the stockholder preference for triennial executive compensation advisory votes.
- Review the approved 2017 Equity Incentive Plan and Employee Stock Purchase Plan terms in separate filings or the company's proxy statement.